Fusing subunit antigens to interleukin-2 and encapsulating them in liposomes improves their antigenicity but not their protective efficacy


Autoria(s): Wales, J. R.; Baird, M. A.; Davies, N. M.; Buchan, G. S.
Contribuinte(s)

J.B. Campbell

K. Yamanishi

R.E. Spier

Data(s)

01/01/2005

Resumo

Subunit vaccines commonly lack sufficient immunogenicity to stimulate a comprehensive protective immune response in vivo. We have investigated the potential of specific cytokines (interleukin-2) and particulate delivery systems (liposomes) to enhance antigenicity. Here we report that the IgG1 and IFN-gamma responses to a subunit antigen, consisting of a T and B-cell epitope from Influenza haemagglutinin, can be improved when it is both fused to interelukin-2 and encapsulated in liposomes. However, this vaccine formulation was not able to protect animals against a challenge with live Influenza A/PR/8/34 virus. The addition of more potent immune stimulators may be necessary to improve responses. (c) 2005 Elsevier Ltd. All rights reserved.

Identificador

http://espace.library.uq.edu.au/view/UQ:76206

Idioma(s)

eng

Publicador

Elsevier

Palavras-Chave #Immunology #Medicine, Research & Experimental #Veterinary Sciences #Liposomes #Interleukin-2 #Subunit Influenza Vaccines #Macrophage #Mice #C1 #320299 Immunology not elsewhere classified #730101 Infectious diseases #11 Medical and Health Sciences #1107 Immunology
Tipo

Journal Article